Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B-Reference-Cited by-同舟云学术

Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B

Published:2012-05-17 Issue:12 Volume:42 Page:1168-1174
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Toyama Takashi,Ishida Hisashi,Ishibashi Hiromi,Yatsuhashi Hiroshi,Nakamuta Makoto,Shimada Masaaki,Ohta Hajime,Satoh Takeaki,Kato Michio,Hijioka Taizo,Takano Hirotsugu,Komeda Toshiki,Yagura Michiyasu,Mano Hiroshi,Watanabe Yukio,Kobayashi Masakazu,Mita Eiji

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Reference25 articles.

1. Chronic hepatitis B;Lok;N Engl J Med,2002

2. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

3. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. Management of chronic hepatitis B;Conjeevaram;J Hepatol,2003

5. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group;Lai;N Engl J Med,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B;Journal of Gastroenterology and Hepatology;2015-12-30

2. Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy;Gut and Liver;2015-05-23

3. Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B;Journal of Gastroenterology and Hepatology;2014-07

4. JSH Guidelines for the Management of Hepatitis B Virus Infection;Hepatology Research;2014-01

5. The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy;Intervirology;2014